AP3199A - Agomelatine hydrobromide hadrate and preparation thereof - Google Patents
Agomelatine hydrobromide hadrate and preparation thereofInfo
- Publication number
- AP3199A AP3199A AP2012006493A AP2012006493A AP3199A AP 3199 A AP3199 A AP 3199A AP 2012006493 A AP2012006493 A AP 2012006493A AP 2012006493 A AP2012006493 A AP 2012006493A AP 3199 A AP3199 A AP 3199A
- Authority
- AP
- ARIPO
- Prior art keywords
- hadrate
- preparation
- agomelatine hydrobromide
- agomelatine
- hydrobromide
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/16—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
- C07C233/17—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
- C07C233/18—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of an acyclic saturated carbon skeleton
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C231/00—Preparation of carboxylic acid amides
- C07C231/12—Preparation of carboxylic acid amides by reactions not involving the formation of carboxamide groups
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Diabetes (AREA)
- Anesthesiology (AREA)
- Endocrinology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2010101262639A CN102190595A (zh) | 2010-03-17 | 2010-03-17 | 阿戈美拉汀溴化氢水合物及其制备方法 |
PCT/CN2011/071912 WO2011113363A1 (en) | 2010-03-17 | 2011-03-17 | Agomelatine hydrobromide hydrate and preparation thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
AP2012006493A0 AP2012006493A0 (en) | 2012-10-31 |
AP3199A true AP3199A (en) | 2015-03-31 |
Family
ID=44599557
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AP2012006493A AP3199A (en) | 2010-03-17 | 2011-03-17 | Agomelatine hydrobromide hadrate and preparation thereof |
Country Status (39)
Country | Link |
---|---|
US (1) | US8729132B2 (uk) |
EP (1) | EP2547650B1 (uk) |
JP (1) | JP5634533B2 (uk) |
KR (1) | KR101406736B1 (uk) |
CN (2) | CN102190595A (uk) |
AP (1) | AP3199A (uk) |
AU (1) | AU2011229619B2 (uk) |
BR (1) | BR112012023173B1 (uk) |
CA (1) | CA2792430C (uk) |
CL (1) | CL2012002541A1 (uk) |
CR (1) | CR20120461A (uk) |
CU (1) | CU20120136A7 (uk) |
CY (1) | CY1117134T1 (uk) |
DK (1) | DK2547650T3 (uk) |
EA (1) | EA022066B1 (uk) |
EC (1) | ECSP12012156A (uk) |
ES (1) | ES2572427T3 (uk) |
GE (1) | GEP20156232B (uk) |
GT (1) | GT201200260A (uk) |
HK (1) | HK1177732A1 (uk) |
HN (1) | HN2012001923A (uk) |
HR (1) | HRP20151343T1 (uk) |
HU (1) | HUE026673T2 (uk) |
IL (1) | IL221783A (uk) |
MA (1) | MA34054B1 (uk) |
ME (1) | ME02309B (uk) |
MX (1) | MX2012010594A (uk) |
MY (1) | MY160337A (uk) |
NI (1) | NI201200141A (uk) |
NZ (1) | NZ602451A (uk) |
PE (1) | PE20130014A1 (uk) |
PL (1) | PL2547650T3 (uk) |
PT (1) | PT2547650E (uk) |
RS (1) | RS54449B1 (uk) |
SG (1) | SG183869A1 (uk) |
SI (1) | SI2547650T1 (uk) |
TN (1) | TN2012000436A1 (uk) |
UA (1) | UA105424C2 (uk) |
WO (1) | WO2011113363A1 (uk) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2978916B1 (fr) | 2011-08-10 | 2013-07-26 | Servier Lab | Composition pharmaceutique solide pour administration buccale d'agomelatine |
CN102718675B (zh) * | 2012-06-07 | 2015-03-25 | 上海右手医药科技开发有限公司 | 阿戈美拉汀甲磺酸复合物及其制备方法 |
EP2851363B1 (en) * | 2012-05-14 | 2018-01-03 | Shanghai Righthand Pharmtech. Co., Ltd. | Agomelatine acid radical composite, and preparation method and application thereof |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2658818B1 (fr) * | 1990-02-27 | 1993-12-31 | Adir Cie | Nouveaux derives a structure naphtalenique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent. |
PL366150A1 (en) * | 2000-10-30 | 2005-01-24 | Teva Pharmaceutical Industries Ltd. | Novel crystal and solvate forms of ondansetron hydrochloride and processes for their preparation |
FR2890562B1 (fr) * | 2005-09-09 | 2012-10-12 | Servier Lab | Utilisation de l'agomelatine pour l'obtention de medicaments destines au traitement des troubles du sommeil chez le patient deprime |
FR2899472B1 (fr) * | 2006-04-07 | 2008-09-12 | Servier Lab | Utilisation de l'agomelatine pour l'obtention de medicaments destines au traitement du trouble anxiete generalisee |
CN101481321B (zh) * | 2009-02-27 | 2012-04-18 | 上海医药工业研究院 | 阿戈美拉汀卤化氢复合物及其制备方法 |
CN101585779B (zh) * | 2009-03-10 | 2014-04-02 | 上海医药工业研究院 | 阿戈美拉汀的晶型vi及其制备方法和应用 |
-
2010
- 2010-03-17 CN CN2010101262639A patent/CN102190595A/zh active Pending
-
2011
- 2011-03-17 SI SI201130723T patent/SI2547650T1/sl unknown
- 2011-03-17 ES ES11755680T patent/ES2572427T3/es active Active
- 2011-03-17 CA CA2792430A patent/CA2792430C/en active Active
- 2011-03-17 BR BR112012023173-1A patent/BR112012023173B1/pt not_active IP Right Cessation
- 2011-03-17 MY MYPI2012700614A patent/MY160337A/en unknown
- 2011-03-17 MA MA35191A patent/MA34054B1/fr unknown
- 2011-03-17 PL PL11755680T patent/PL2547650T3/pl unknown
- 2011-03-17 SG SG2012065017A patent/SG183869A1/en unknown
- 2011-03-17 ME MEP-2016-9A patent/ME02309B/me unknown
- 2011-03-17 RS RS20150831A patent/RS54449B1/en unknown
- 2011-03-17 WO PCT/CN2011/071912 patent/WO2011113363A1/en active Application Filing
- 2011-03-17 DK DK11755680.3T patent/DK2547650T3/en active
- 2011-03-17 HU HUE11755680A patent/HUE026673T2/en unknown
- 2011-03-17 PE PE2012001449A patent/PE20130014A1/es active IP Right Grant
- 2011-03-17 KR KR1020127026897A patent/KR101406736B1/ko active IP Right Grant
- 2011-03-17 UA UAA201211719A patent/UA105424C2/uk unknown
- 2011-03-17 EP EP11755680.3A patent/EP2547650B1/en active Active
- 2011-03-17 GE GEAP201112870A patent/GEP20156232B/en unknown
- 2011-03-17 EA EA201201293A patent/EA022066B1/ru unknown
- 2011-03-17 MX MX2012010594A patent/MX2012010594A/es active IP Right Grant
- 2011-03-17 NZ NZ602451A patent/NZ602451A/en not_active IP Right Cessation
- 2011-03-17 AU AU2011229619A patent/AU2011229619B2/en not_active Ceased
- 2011-03-17 AP AP2012006493A patent/AP3199A/xx active
- 2011-03-17 CN CN201180024413.8A patent/CN102892749B/zh not_active Expired - Fee Related
- 2011-03-17 JP JP2012557393A patent/JP5634533B2/ja not_active Expired - Fee Related
- 2011-03-17 PT PT117556803T patent/PT2547650E/pt unknown
- 2011-03-17 US US13/635,087 patent/US8729132B2/en active Active
-
2012
- 2012-08-31 TN TNP2012000436A patent/TN2012000436A1/en unknown
- 2012-09-04 IL IL221783A patent/IL221783A/en not_active IP Right Cessation
- 2012-09-11 CR CR20120461A patent/CR20120461A/es unknown
- 2012-09-12 NI NI201200141A patent/NI201200141A/es unknown
- 2012-09-13 CL CL2012002541A patent/CL2012002541A1/es unknown
- 2012-09-14 EC ECSP12012156 patent/ECSP12012156A/es unknown
- 2012-09-14 HN HN2012001923A patent/HN2012001923A/es unknown
- 2012-09-17 CU CU2012000136A patent/CU20120136A7/es unknown
- 2012-09-17 GT GT201200260A patent/GT201200260A/es unknown
-
2013
- 2013-04-23 HK HK13104895.3A patent/HK1177732A1/xx not_active IP Right Cessation
-
2015
- 2015-12-08 HR HRP20151343TT patent/HRP20151343T1/hr unknown
-
2016
- 2016-01-18 CY CY20161100041T patent/CY1117134T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUS2100032I1 (hu) | Helyettesített 5-fluor-1H-pirazolopiridin-származékok és alkalmazásuk | |
HK1187049A1 (en) | Bisaryl-bonded aryltriazolones and use thereof | |
EP2657188A4 (en) | FLUOROGRAPHIC AND METHOD FOR PREPARING THE SAME | |
HRP20150071T1 (en) | Agomelatine hydrochloride hydrate and preparation thereof | |
PT2605757E (pt) | Formulações à base de nalbufina e suas utilizações | |
ZA201302854B (en) | Substituted benzamides and their uses | |
EP2608785A4 (en) | LIPOMA CYCLES AND ITS USES | |
PT2521445T (pt) | Formulação e utilização da mesma | |
IL223180A0 (en) | Agomelatine intermediates and preparation method thereof | |
EP2529013A4 (en) | NOVEL BETA GLUCOSIDASE AND USES THEREOF | |
AP3199A (en) | Agomelatine hydrobromide hadrate and preparation thereof |